glp-1 and thyroid disease Frontiers Can I Take GLP-1 With

Neurourol Urodyn 2021

(2023) found that GLP-1 receptor agonists reduced the risk of lower limb amputation by 43% compared to sulfonylureas (HR: 0.57, 95% CI: 0.390.84), with the greatest risk reduction observed in long-term users (HR: 0.44, 95% CI: 0.270.72).(26) However, GLP-1 receptor agonists did not significantly impact diabetic foot ulcer incidence (HR: 1.08, 95% CI: 0.871.35)

Advanced dinner strategies for experienced GLP-1 users Once you have the basics down, these advanced strategies optimize dinner for maximum results on your GLP-1 protocol

doi: 10.1210/me.2011-1023

The absence of estrogens has a significant effect on obesity in menopausal women ( 20 , 21 )

Carney complex: An update